RxDoctor Payments Data

Brian Gartrell, MD

Family Medicine · Council Bluffs, IANPI 1225262538

Payments from drug & device makers

$981in general payments, 2019–2025

Across 63 payments — averaging $15.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$243
  • Amgen$211
  • Novo Nordisk$137
  • Novartis$76
  • Johnson & Johnson$52
  • Takeda Pharmaceuticals U.S.A., Inc.$36
  • plus $226 from 12 others

What the payments were for

  • Food & beverage$981100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$981 in reported general payments places this provider in the 80th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$402,107
Medicare patients
363
Services billed
12,859

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban171$139,951
OzempicSemaglutide89$86,343
JardianceEmpagliflozin86$78,918
TrulicityDulaglutide53$58,446
XareltoRivaroxaban52$52,496
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$49,675
MounjaroTirzepatide39$43,322
FarxigaDapagliflozin Propanediol52$42,441
Repatha SureclickEvolocumab38$31,026
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr36$24,341
Repatha SyringeEvolocumab24$19,839
Breo ElliptaFluticasone/Vilanterol31$18,311
QuliptaAtogepant13$16,485
Spiriva RespimatTiotropium Bromide27$15,345
MyrbetriqMirabegron23$13,029

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$139,951171 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog$17$104,028111 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta$33$101,488155 claims
Novo NordiskOzempic$137$86,34389 claims
Johnson & JohnsonXarelto$52$52,49652 claims
AstraZenecaFarxiga$22$42,44152 claims
AbbVieQulipta, Synthroid$243$19,71953 claims
MerckJanumet$15$6,15211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Council Bluffs

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →